PKBK:NASDAQParke Bancorp, Inc. Analysis
Data as of 2026-04-24 - not real-time
$30.02
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Parke Bancorp’s stock is trading comfortably above its 20‑day, 50‑day and 200‑day moving averages, indicating a sustained bullish momentum. The price sits near the upper end of its recent range, supported by a 20‑day SMA that sits above the 50‑day SMA and a bullish MACD crossover, while the RSI in the mid‑60s suggests room for further upside before overbought conditions emerge.
Fundamentally, the company posted a 35% revenue surge and boasts exceptionally high operating (≈70%) and profit margins, delivering a P/E ratio less than half the industry average, which points to clear undervaluation. A 2.4% dividend yield backed by a modest 20% payout ratio, low beta, and manageable debt levels reinforce the attractiveness of the stock for income‑oriented investors, though the decreasing volume trend hints at limited short‑term liquidity.
Fundamentally, the company posted a 35% revenue surge and boasts exceptionally high operating (≈70%) and profit margins, delivering a P/E ratio less than half the industry average, which points to clear undervaluation. A 2.4% dividend yield backed by a modest 20% payout ratio, low beta, and manageable debt levels reinforce the attractiveness of the stock for income‑oriented investors, though the decreasing volume trend hints at limited short‑term liquidity.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup with price above key moving averages
- RSI below overbought threshold
- Support level just below current price
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high operating margins
- Undervalued valuation relative to peers
- Sustainable dividend yield
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable cash flow generation supporting dividend continuity
- Low beta indicating defensive characteristics
- Potential headwinds from regional banking regulatory environment
Key Metrics & Analysis
Financial Health
Revenue Growth35.30%
Profit Margin50.21%
P/E Ratio8.6
ROE13.05%
ROA1.92%
P/B Ratio1.0
Industry P/E17.3
Technical Analysis
TrendBullish
RSI64.5
Support$27.94
Resistance$31.45
MA 20$29.30
MA 50$28.45
MA 200$24.35
MACDBullish
VolumeDecreasing
Fear & Greed Index88.02
Valuation
GradeUndervalued
TypeBlend
Dividend Yield2.41%
Risk Assessment
Beta0.75
Volatility17.69%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.